Edition:
United Kingdom

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

9.01USD
17 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$9.01
Open
--
Day's High
--
Day's Low
--
Volume
400
Avg. Vol
70,323
52-wk High
$35.52
52-wk Low
$8.91

Chart for

About

Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocyt... (more)

Overall

Beta: --
Market Cap(Mil.): $714.42
Shares Outstanding(Mil.): 25.65
Dividend: --
Yield (%): --

Financials

  DOVA.OQ Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -0.92 -- --
ROI: -- 9.00 14.96
ROE: -- 10.14 16.53

Earnings vs. Estimates